[-] Show simple item record

dc.contributor.authorEpling, John W.eng
dc.date.issued2003-12eng
dc.description.abstractFluoxetine (Prozac) use may result in an average, short-term weight loss of up to 3.3 kg (7 lb, 4 oz) in obese patients, but the longterm effects and maintenance of weight loss after discontinuation of the drug have not been well studied. No evidence concerning other SSRIs was found. [Strength of recommendation: B, based on low-quality systematic reviews of randomized controlled trials (RCTs)]eng
dc.identifier.citationAmerican Family Physician, 68(12) 2003: 2437-2438.eng
dc.identifier.urihttp://hdl.handle.net/10355/11917eng
dc.languageEnglisheng
dc.publisherFamily Physicians Inquiry Networkeng
dc.relation.ispartofClinical Inquiries, 2003 (MU)eng
dc.relation.ispartofcollectionUniversity of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Networkeng
dc.subject.lcshSerotonin uptake inhibitorseng
dc.subject.lcshObesityeng
dc.titleIs Fluoxetine an Effective Therapy for Weight Loss in Obese Patients?eng
dc.typeArticleeng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record